Tudor Investment Corp’s Omega Protein OME Stock Holding History

Tudor Investment Corp’s Portfolio OME Stock Details OME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-18,081	Closed	-$301K	–	1417
2017 Q3	$301K	Sell	18,081 -2,099	-10%	-$34.1K	0.01%	828
2017 Q2	$361K	Sell	20,180 -38,249	-65%	-$715K	0.01%	694
2017 Q1	$1.17M	Buy	58,429 +15,446	+36%	+$360K	0.04%	323
2016 Q4	$1.08M	Buy	42,983 +14,912	+53%	+$352K	0.03%	339
2016 Q3	$656K	Sell	28,071 -1,037	-4%	-$24.4K	0.02%	594
2016 Q2	$582K	Buy	29,108 +11,591	+66%	+$216K	0.01%	735
2016 Q1	$297K	Sell	17,517 -4,066	-19%	-$83.3K	0.01%	1302
2015 Q4	$479K	Buy	+21,583	New	+$449K	0.01%	916
2014 Q4	–	Sell	-17,530	Closed	-$219K	–	1678
2014 Q3	$219K	Buy	+17,530	New	+$244K	0.01%	1155

Tudor Investment Corp's OME Position: Q4 2017 in Review

Tudor Investment Corp sold out of Omega Protein (OME) in Q4 2017, closing a stake of 18,081 shares — an estimated $301K sold.

Tudor Investment Corp first reported a position in OME in Q3 2014 and held it in 9 quarters. The position peaked at $1.17M in Q1 2017. 0 funds tracked by Wall St. Rank hold OME as of Q4 2017.

Tudor Investment Corp reported no remaining Omega Protein position as of Q4 2017 after selling out during the quarter.
Tudor Investment Corp sold 18,081 Omega Protein shares in Q4 2017, an estimated $301K.
Tudor Investment Corp first reported a position in Omega Protein in Q3 2014 and held it in 9 quarters.
Tudor Investment Corp's Omega Protein position peaked at $1.17M in Q1 2017.
0 funds tracked by Wall St. Rank held Omega Protein as of Q4 2017.

Based on Tudor Investment Corp's 13F filing for Q4 2017, filed 14 Feb 2018.